-
1
-
-
79956348095
-
Loss of tolerance to self after transplant
-
doi:10.1007/s00281-011-0252-1
-
Keller MR, Burlingham WJ. Loss of tolerance to self after transplant. Semin Immunopathol. 2011;33(2):105-10. doi:10.1007/s00281-011-0252-1.
-
(2011)
Semin Immunopathol
, vol.33
, Issue.2
, pp. 105-110
-
-
Keller, M.R.1
Burlingham, W.J.2
-
2
-
-
84877875044
-
Antibody-mediated rejection in kidney transplantation: A review
-
doi:10.1155/2012/193724
-
Puttarajappa C, Shapiro R, Tan HP. Antibody-mediated rejection in kidney transplantation: a review. J Transplant. 2012;2012:193724. doi:10.1155/2012/ 193724.
-
(2012)
J Transplant
, vol.2012
, pp. 193724
-
-
Puttarajappa, C.1
Shapiro, R.2
Tan, H.P.3
-
3
-
-
79956344354
-
Steroids in kidney transplant patients
-
doi:10.1007/s00281-011-0259-7
-
Steiner RW, Awdishu L. Steroids in kidney transplant patients. Semin Immunopathol. 2011;33(2):157-67. doi:10.1007/s00281-011-0259-7.
-
(2011)
Semin Immunopathol
, vol.33
, Issue.2
, pp. 157-167
-
-
Steiner, R.W.1
Awdishu, L.2
-
4
-
-
79955660456
-
Induction immunosuppressive therapies in renal transplantation
-
doi:10.2146/ajhp090636
-
Gabardi S, Martin ST, Roberts KL, Grafals M. Induction immunosuppressive therapies in renal transplantation. Am J Health Syst Pharm. 2011;68(3):211-8. doi:10.2146/ajhp090636.
-
(2011)
Am J Health Syst Pharm
, vol.68
, Issue.3
, pp. 211-218
-
-
Gabardi, S.1
Martin, S.T.2
Roberts, K.L.3
Grafals, M.4
-
5
-
-
79960498901
-
Use of monoclonal antibodies in renal transplantation
-
doi:10.2217/imt.11.72
-
van den Hoogen MW, Hilbrands LB. Use of monoclonal antibodies in renal transplantation. Immunotherapy. 2011;3(7):871-80. doi:10.2217/imt.11.72.
-
(2011)
Immunotherapy
, vol.3
, Issue.7
, pp. 871-880
-
-
Van Den Hoogen, M.W.1
Hilbrands, L.B.2
-
6
-
-
77953654209
-
Antibody immunosuppressive therapy in solid-organ transplant: Part I
-
Mahmud N, Klipa D, Ahsan N. Antibody immunosuppressive therapy in solid-organ transplant: part I. MAbs. 2010;2(2):148-56.
-
(2010)
MAbs
, vol.2
, Issue.2
, pp. 148-156
-
-
Mahmud, N.1
Klipa, D.2
Ahsan, N.3
-
7
-
-
0242464926
-
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4? T lymphocytes
-
doi:10.1172/JCI16432
-
Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4? T lymphocytes. J Clin Invest. 2003;111(8):1133-45. doi:10.1172/JCI16432.
-
(2003)
J Clin Invest
, vol.111
, Issue.8
, pp. 1133-1145
-
-
Tiede, I.1
Fritz, G.2
Strand, S.3
Poppe, D.4
Dvorsky, R.5
Strand, D.6
-
8
-
-
0032822859
-
An alternate mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile
-
Almawi WY, Melemedjian OK, Rieder MJ. An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant. 1999;13(5):365-74.
-
(1999)
Clin Transplant
, vol.13
, Issue.5
, pp. 365-374
-
-
Almawi, W.Y.1
Melemedjian, O.K.2
Rieder, M.J.3
-
9
-
-
33644784718
-
Corticosteroids: The drugs to beat
-
doi:10.1016/j.ejphar.2005.12.052
-
Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol. 2006;533(1-3):2-14. doi:10.1016/j.ejphar.2005.12.052.
-
(2006)
Eur J Pharmacol
, vol.533
, Issue.1-3
, pp. 2-14
-
-
Barnes, P.J.1
-
10
-
-
0030272487
-
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: Tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
-
Brazelton TR, Morris RE. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol. 1996;8(5):710-20.
-
(1996)
Curr Opin Immunol
, vol.8
, Issue.5
, pp. 710-720
-
-
Brazelton, T.R.1
Morris, R.E.2
-
11
-
-
0001432909
-
From laboratory to clinic: The story of CAM PA TH-1
-
doi:10.1385/1-59259-076-4:243
-
Hale G, Waldmann H. From laboratory to clinic: the story of CAM PA TH-1. Methods Mol Med. 2000;40:243-66. doi:10.1385/1-59259-076-4:243.
-
(2000)
Methods Mol Med
, vol.40
, pp. 243-266
-
-
Hale, G.1
Waldmann, H.2
-
12
-
-
54349101243
-
Emerging role of alemtuzumab in renal and renal-pancreas transplantation
-
doi:10.1517/14712598.8.10.1605
-
Sureshkumar KK, Hussain SM, Zimmer BW, Marcus RJ. Emerging role of alemtuzumab in renal and renal-pancreas transplantation. Expert Opin Biol Ther. 2008;8(10):1605-25. doi:10.1517/14712598.8.10.1605.
-
(2008)
Expert Opin Biol Ther
, vol.8
, Issue.10
, pp. 1605-1625
-
-
Sureshkumar, K.K.1
Hussain, S.M.2
Zimmer, B.W.3
Marcus, R.J.4
-
13
-
-
0035555519
-
Pharmacokinetics of CAMPATH-1H in BMT patients
-
doi:10.1080/146532401317070899
-
Rebello P, Cwynarski K, Varughese M, Eades A, Apperley JF, Hale G. Pharmacokinetics of CAMPATH-1H in BMT patients. Cytotherapy. 2001;3(4):261-7. doi:10.1080/146532401317070899.
-
(2001)
Cytotherapy
, vol.3
, Issue.4
, pp. 261-267
-
-
Rebello, P.1
Cwynarski, K.2
Varughese, M.3
Eades, A.4
Apperley, J.F.5
Hale, G.6
-
14
-
-
79952500113
-
Alemtuzumab induction therapy in highly sensitized kidney transplant recipients
-
Lu TM, Yang SL, Wu WZ, Tan JM. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients. Chin Med J (Engl). 2011;124(5):664-8.
-
(2011)
Chin Med J (Engl)
, vol.124
, Issue.5
, pp. 664-668
-
-
Lu, T.M.1
Yang, S.L.2
Wu, W.Z.3
Tan, J.M.4
-
15
-
-
26644457880
-
Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
-
pii: 00007890-200509270-00009
-
Vathsala A, Ona ET, Tan SY, Suresh S, Lou HX, Casasola CB, et al. Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation. Transplantation 2005;80(6):765-74. pii: 00007890-200509270-00009.
-
(2005)
Transplantation
, vol.80
, Issue.6
, pp. 765-774
-
-
Vathsala, A.1
Ona, E.T.2
Tan, S.Y.3
Suresh, S.4
Lou, H.X.5
Casasola, C.B.6
-
16
-
-
79956189911
-
Alemtuzumab induction in renal transplantation
-
doi:10.1056/NEJMoa1009546
-
Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, et al. Alemtuzumab induction in renal transplantation. N Engl J Med. 2011;364(20):1909-19. doi:10.1056/NEJMoa1009546.
-
(2011)
N Engl J Med
, vol.364
, Issue.20
, pp. 1909-1919
-
-
Hanaway, M.J.1
Woodle, E.S.2
Mulgaonkar, S.3
Peddi, V.R.4
Kaufman, D.B.5
First, M.R.6
-
17
-
-
20144389244
-
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or Campath
-
(quiz A59-61). doi:10.1016/j.jamcollsurg.2004.12.024
-
Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or Campath. J Am Coll Surg. 2005;200(4):505-15 (quiz A59-61). doi:10.1016/j.jamcollsurg.2004.12.024.
-
(2005)
J Am Coll Surg
, vol.200
, Issue.4
, pp. 505-515
-
-
Shapiro, R.1
Basu, A.2
Tan, H.3
Gray, E.4
Kahn, A.5
Randhawa, P.6
-
18
-
-
31044452372
-
Campath-1H induction and the incidence of infectious complications in adult renal transplantation
-
pii: 00007890-200601150-00005
-
Malek SK, Obmann MA, Gotoff RA, Foltzer MA, Hartle JE, Potdar S. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation 2006;81(1):17-20. pii: 00007890-200601150-00005.
-
(2006)
Transplantation
, vol.81
, Issue.1
, pp. 17-20
-
-
Malek, S.K.1
Obmann, M.A.2
Gotoff, R.A.3
Foltzer, M.A.4
Hartle, J.E.5
Potdar, S.6
-
19
-
-
33845929149
-
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection
-
doi:10.1097/01.tp.0000250655.14026.5c
-
Thai NL, Blisard D, Tom K, Basu A, Smetanka C, Tan H, et al. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: correlation between low T-cell responses and infection. Transplantation. 2006;82(12):1649-52. doi:10.1097/01.tp.0000250655.14026.5c.
-
(2006)
Transplantation
, vol.82
, Issue.12
, pp. 1649-1652
-
-
Thai, N.L.1
Blisard, D.2
Tom, K.3
Basu, A.4
Smetanka, C.5
Tan, H.6
-
20
-
-
0037469040
-
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation
-
doi:10.1097/01.TP.0000065192.53065.50
-
Tzakis AG, Kato T, Nishida S, Levi DM, Madariaga JR, Nery JR, et al. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation. 2003;75(8):1227-31. doi:10.1097/01.TP. 0000065192.53065.50.
-
(2003)
Transplantation
, vol.75
, Issue.8
, pp. 1227-1231
-
-
Tzakis, A.G.1
Kato, T.2
Nishida, S.3
Levi, D.M.4
Madariaga, J.R.5
Nery, J.R.6
-
21
-
-
67649172198
-
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients
-
doi:10.1002/lt.21666
-
Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transplant. 2009;15(2):216-22. doi:10.1002/lt.21666.
-
(2009)
Liver Transplant
, vol.15
, Issue.2
, pp. 216-222
-
-
Cabrera, R.1
Ararat, M.2
Soldevila-Pico, C.3
Dixon, L.4
Pan, J.J.5
Firpi, R.6
-
22
-
-
77950859103
-
The evolving role of alemtuzumab (Campath-1H) in renal transplantation
-
Pham PT, Lipshutz GS, Kawahji J, Singer JS, Pham PC. The evolving role of alemtuzumab (Campath-1H) in renal transplantation. Drug Des Dev Ther. 2009;3:41-9.
-
(2009)
Drug Des Dev Ther
, vol.3
, pp. 41-49
-
-
Pham, P.T.1
Lipshutz, G.S.2
Kawahji, J.3
Singer, J.S.4
Pham, P.C.5
-
23
-
-
73349119091
-
Immunosuppressive drugs and Tregs: A critical evaluation!
-
doi:10.2215/CJN.03180509
-
De Serres SA, Sayegh MH, Najafian N. Immunosuppressive drugs and Tregs: a critical evaluation! Clin J Am Soc Nephrol. 2009;4(10):1661-9. doi:10.2215/CJN.03180509.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, Issue.10
, pp. 1661-1669
-
-
De Serres, S.A.1
Sayegh, M.H.2
Najafian, N.3
-
24
-
-
80052705284
-
Assessing immunologic function through CD4 T-lymphocyte adenosine triphosphate levels by ImmuKnow assay in Chinese patients following renal transplantation
-
doi:10.1016/j.transproceed.2011.04.012
-
Zhou H, Wu Z, Ma L, Wu W, Yang S, Wang Q, et al. Assessing immunologic function through CD4 T-lymphocyte adenosine triphosphate levels by ImmuKnow assay in Chinese patients following renal transplantation. Transplant Proc. 2011;43(7):2574-8. doi:10.1016/j.transproceed.2011.04.012.
-
(2011)
Transplant Proc
, vol.43
, Issue.7
, pp. 2574-2578
-
-
Zhou, H.1
Wu, Z.2
Ma, L.3
Wu, W.4
Yang, S.5
Wang, Q.6
-
25
-
-
0034052928
-
Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP
-
Sottong PR, Rosebrock JA, Britz JA, Kramer TR. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin Diagn Lab Immunol. 2000;7(2):307-11.
-
(2000)
Clin Diagn Lab Immunol
, vol.7
, Issue.2
, pp. 307-311
-
-
Sottong, P.R.1
Rosebrock, J.A.2
Britz, J.A.3
Kramer, T.R.4
-
26
-
-
0037626590
-
Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management
-
Kowalski R, Post D, Schneider MC, Britz J, Thomas J, Deierhoi M, et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003;17(2):77-88.
-
(2003)
Clin Transplant
, vol.17
, Issue.2
, pp. 77-88
-
-
Kowalski, R.1
Post, D.2
Schneider, M.C.3
Britz, J.4
Thomas, J.5
Deierhoi, M.6
-
27
-
-
77949414863
-
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection
-
doi:10.1097/TP.0b013e3181c690fa
-
Xue F, Zhang J, Han L, Li Q, Xu N, Zhou T, et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation. 2010;89(5):620-6. doi:10.1097/TP.0b013e3181c690fa.
-
(2010)
Transplantation
, vol.89
, Issue.5
, pp. 620-626
-
-
Xue, F.1
Zhang, J.2
Han, L.3
Li, Q.4
Xu, N.5
Zhou, T.6
-
28
-
-
0027496071
-
Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs
-
Schulick RD, Weir MB, Miller MW, Cohen DJ, Bermas BL, Shearer GM. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation. 1993;56(3):590-6.
-
(1993)
Transplantation
, vol.56
, Issue.3
, pp. 590-596
-
-
Schulick, R.D.1
Weir, M.B.2
Miller, M.W.3
Cohen, D.J.4
Bermas, B.L.5
Shearer, G.M.6
-
29
-
-
0034177660
-
Bioenergetics of immune functions: Fundamental and therapeutic aspects
-
pii: S0167569900015930
-
Buttgereit F, Burmester GR, Brand MD. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today. 2000;21(4):192-9. pii: S0167569900015930.
-
(2000)
Immunol Today
, vol.21
, Issue.4
, pp. 192-199
-
-
Buttgereit, F.1
Burmester, G.R.2
Brand, M.D.3
-
30
-
-
79955472274
-
Screening of mortality in transplant patients using an assay for immune function
-
doi:10.1016/j.trim.2010.12.005
-
Berglund D, Bengtsson M, Biglarnia A, Berglund E, Yamamoto S, von Zur-Muhlen B, et al. Screening of mortality in transplant patients using an assay for immune function. Transpl Immunol. 2011;24(4):246-50. doi:10.1016/j.trim.2010.12.005.
-
(2011)
Transpl Immunol
, vol.24
, Issue.4
, pp. 246-250
-
-
Berglund, D.1
Bengtsson, M.2
Biglarnia, A.3
Berglund, E.4
Yamamoto, S.5
Von Zur-Muhlen, B.6
-
31
-
-
80051678906
-
Lack of association of immune cell function test with rejection in kidney transplantation
-
doi:10.1016/j.transproceed.2011.06.056
-
Torio A, Fernandez EJ, Montes-Ares O, Guerra RM, Perez MA, Checa MD. Lack of association of immune cell function test with rejection in kidney transplantation. Transplant Proc. 2011;43(6):2168-70. doi:10.1016/j. transproceed.2011.06.056.
-
(2011)
Transplant Proc
, vol.43
, Issue.6
, pp. 2168-2170
-
-
Torio, A.1
Fernandez, E.J.2
Montes-Ares, O.3
Guerra, R.M.4
Perez, M.A.5
Checa, M.D.6
-
32
-
-
79957626523
-
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation
-
doi:10.1016/j.transproceed.2011.02.043
-
De Paolis P, Favaro A, Piola A, Martini F, Cristiana G, Agrati C, et al. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. Transplant Proc. 2011;43(4):1013-6. doi:10.1016/j.transproceed.2011.02.043.
-
(2011)
Transplant Proc
, vol.43
, Issue.4
, pp. 1013-1016
-
-
De Paolis, P.1
Favaro, A.2
Piola, A.3
Martini, F.4
Cristiana, G.5
Agrati, C.6
-
33
-
-
33748690103
-
Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay
-
doi:10.1097/01.tp.0000234837.02126.70
-
Kowalski RJ, Post DR, Mannon RB, Sebastian A, Wright HI, Sigle G, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82(5):663-8. doi:10.1097/01.tp. 0000234837.02126.70.
-
(2006)
Transplantation
, vol.82
, Issue.5
, pp. 663-668
-
-
Kowalski, R.J.1
Post, D.R.2
Mannon, R.B.3
Sebastian, A.4
Wright, H.I.5
Sigle, G.6
-
34
-
-
20544458513
-
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years
-
doi:10.1111/j.1600-6143.2005.00822.x
-
Watson CJ, Bradley JA, Friend PJ, Firth J, Taylor CJ, Bradley JR, et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years. Am J Transplant. 2005;5(6):1347-53. doi:10.1111/j.1600-6143.2005.00822.x.
-
(2005)
Am J Transplant
, vol.5
, Issue.6
, pp. 1347-1353
-
-
Watson, C.J.1
Bradley, J.A.2
Friend, P.J.3
Firth, J.4
Taylor, C.J.5
Bradley, J.R.6
-
35
-
-
56049108111
-
Alemtuzumab induction in kidney transplantation: Clinical results and impact on T-regulatory cells
-
doi:10.1016/j.transproceed.2008.03.066
-
Morales J, Bono MR, Fierro A, Iniguez R, Zehnder C, Rosemblatt M, et al. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells. Transplant Proc. 2008;40(9):3223-8. doi:10.1016/j. transproceed.2008.03.066.
-
(2008)
Transplant Proc
, vol.40
, Issue.9
, pp. 3223-3228
-
-
Morales, J.1
Bono, M.R.2
Fierro, A.3
Iniguez, R.4
Zehnder, C.5
Rosemblatt, M.6
|